Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Adial Pharmaceuticals, Inc (ADIL)

Pharmaceutical Preparations

https://www.adialpharma.com

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

1180 SEMINOLE TRAIL, SUITE 495
CHARLOTTESVILLE, VA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/27/2018

Market Cap

6,129,956

Shares Outstanding

1,660,000

Weighted SO

1,217,981

Total Employees

N/A

Upcoming Earnings

08/19/2024

Similar Tickers

RNAZ --.--%

ADTX --.--%

RVPH --.--%

ATXI --.--%

AMTI --.--%

CBIO --.--%

ALRN --.--%

BPTH --.--%

BNTC --.--%

Beta

1.3080

Last Div

0.0000

Range

0.77-4.46

Chg

-0.0118

Avg Vol

2855262

Mkt Cap

6129956

Exch

NASDAQ

Country

US

Phone

434 422 9800

DCF Diff

-1.0342

DCF

1.9844

Div Yield

0.0000

P/S

190.0997

EV Multiple

-0.3907

P/FV

0.9362

Div Yield %

0.0000

P/E

-0.3271

PEG

-0.0033

Payout

0.0000

Current Ratio

5.6906

Quick Ratio

5.6906

Cash Ratio

4.8938

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

204973.3865

CCC

-204973.3865

Gross Margin

0.9825

Op Margin

-225.5792

Pretax Margin

-377.9382

Net Margin

-379.5871

Eff Tax Rate

-0.0044

ROA

-2.4734

ROE

-2.9106

ROCE

-1.7008

NI/EBT

1.0044

EBT/EBIT

1.6754

EBIT/Rev

-225.5792

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-488.4519

CF/Debt

0.0000

Equity Multi

1.1571

Rec Turnover

0.0000

Pay Turnover

0.0018

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0065

OCF/Share

-1.5272

FCF/Share

-1.5272

Cash/Share

0.7861

OCF/Sales

-198.1002

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.9362

P/B

0.9362

P/S

190.0997

P/E

-0.3271

P/FCF

-0.9596

P/OCF

-0.6268

P/CF

-0.6268

PEG

-0.0033

P/S

190.0997

EV Multiple

-0.3907

P/FV

0.9362

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 14, 17:02 Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update GlobeNewswire Inc. Oct 31, 08:30 Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference GlobeNewswire Inc. Oct 24, 16:30 Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Revenue Product Segmentation